144 related articles for article (PubMed ID: 6180371)
1. Plasma arginine esterase in cystic fibrosis: kinetics of activation, identification as plasma kallikrein, reaction with alpha 2-macroglobulin and comparison with levels in normal plasma.
Bury AF; Barrett AJ
Pediatr Res; 1982 Aug; 16(8):613-20. PubMed ID: 6180371
[TBL] [Abstract][Full Text] [Related]
2. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
Goldsmith GH; Stern RC; Saito H; Ratnoff OD
J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
[TBL] [Abstract][Full Text] [Related]
3. Studies on cystic fibrosis using isoelectric focusing. II. Demonstration of deficient proteolytic cleavage of alpha2-macroglobulin in cystic fibrosis plasma.
Wilson GB; Fudenberg HH
Pediatr Res; 1976 Feb; 10(2):87-96. PubMed ID: 54896
[TBL] [Abstract][Full Text] [Related]
4. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
Harpel PC
J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
[TBL] [Abstract][Full Text] [Related]
5. Plasma arginine esterase activity in cystic fibrosis of the pancreas.
Chan KY; Applegarth DA; Davidson AG
Clin Chim Acta; 1977 Jan; 74(1):71-5. PubMed ID: 832413
[TBL] [Abstract][Full Text] [Related]
6. Anomalous alpha 2-macroglobulin-protease complexes in cystic fibrosis: decreased uptake of the complexes by fibroblasts in culture.
Van Leuven F; Cassiman JJ; Van Den Berghe H
Pediatr Res; 1979 Dec; 13(12):1384-6. PubMed ID: 93265
[TBL] [Abstract][Full Text] [Related]
7. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
Kallen RJ; Lee SK
Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
[TBL] [Abstract][Full Text] [Related]
8. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.
Colman RW; Mattler L; Sherry S
J Clin Invest; 1969 Jan; 48(1):23-32. PubMed ID: 4237065
[TBL] [Abstract][Full Text] [Related]
9. Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.
Harpel PC
J Clin Invest; 1971 Oct; 50(10):2084-90. PubMed ID: 5165598
[TBL] [Abstract][Full Text] [Related]
10. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
Schmaier AH; Gustafson E; Idell S; Colman RW
J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
[TBL] [Abstract][Full Text] [Related]
11. Absence of an alpha two-macroglobulin-protease complex in cystic fibrosis.
Shapira E; Rao GJ; Wessel HU; Nadler NL
Pediatr Res; 1976 Sep; 10(9):812-7. PubMed ID: 60735
[TBL] [Abstract][Full Text] [Related]
12. [Nature of the proteinase activated by the contact factor in human blood plasma].
Veremeenko KN; Kizim AI; Lositskaia VM
Vopr Med Khim; 1977; (3):391-6. PubMed ID: 196405
[TBL] [Abstract][Full Text] [Related]
13. The trypsin-inhibitory efficiency of human alpha 2-macroglobulin in the presence of alpha 1-proteinase inhibitor: evidence for the formation of an alpha 2-macroglobulin--alpha 1-proteinase inhibitor complex.
Dejgaard S; Ortapamuk O; Ozer I
J Enzyme Inhib; 1999; 14(5):391-405. PubMed ID: 10488249
[TBL] [Abstract][Full Text] [Related]
14. [Status of the kallikrein-kinin system of the blood in young and middle-aged patients with ischemic heart disease].
Tsagikian TA; Frolova IA; Paramonova EG
Vopr Med Khim; 1984; 30(1):104-8. PubMed ID: 6200999
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of kallikrein in human plasma.
van der Graaf F; Koedam JA; Bouma BN
J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
[TBL] [Abstract][Full Text] [Related]
16. Immunochemical studies of plasma kallikrein.
Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
[TBL] [Abstract][Full Text] [Related]
17. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
[TBL] [Abstract][Full Text] [Related]
18. [Chromatographic separation of activated proteases from human plasma].
Lehmann B; Taucher M; Kühne H; Scheuch DW
Biomed Biochim Acta; 1988; 47(4-5):363-71. PubMed ID: 2467663
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the structure and aspects of the proteinase-binding properties of cystic fibrotic alpha-macroglobulin with normal alpha 2-macroglobulin.
Roberts RC; Nelles LP; Hall PK; Salvesen GS; Mischler E
Pediatr Res; 1982 Jun; 16(6):416-23. PubMed ID: 6179035
[TBL] [Abstract][Full Text] [Related]
20. Competition for trypsin binding between alpha 2-macroglobulin and antitrypsin antibodies in cystic fibrosis.
Romeo G; Denaro M; Parsons M
J Lab Clin Med; 1980 Jan; 95(1):116-24. PubMed ID: 6153109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
